Literature DB >> 26656132

Present Status of Renal Replacement Therapy in Asian Countries.

Pavan Kumar Rao Navva1, Subramanyam Venkata Sreepada, Karopadi Shivanand Nayak.   

Abstract

BACKGROUND: Asia is a huge and populous continent with diverse economies where the status of renal replacement therapy varies among different countries.
SUMMARY: The penetration of dialysis is poor among low income countries like India and China. A lack of trained nephrologists and limited numbers of dialysis facilities plague South Asian countries. Most of the hemodialysis centers are in the private sector; the few centers that are government-run or run by charitable organizations cannot meet growing needs. China has shown that twice-a-week hemodialysis can be feasible in female patients with small build. Peritoneal dialysis (PD) has less penetration among the developing countries than the developed countries in Asia. Novel schemes in India including the 'once-in-a-lifetime payment' scheme and an insurance scheme for peritonitis are attracting more patients to PD. New biocompatible PD solutions and home care facilities have brought down the peritonitis rates. The PD-first policy in Thailand alongside the domestic manufacture of PD fluids has decreased the cost of PD there. Iran has shown drastic changes in its PD policy (from 0 to 1,150 recruitments in 5 years) in spite of its high transplantation rate. Home hemodialysis is practiced in mostly affluent countries like Japan, where again it accounts for only 0.1% of all hemodialysis. KEY MESSAGES: Developing countries should have more budgetary allocation for chronic ailments such as chronic kidney disease that can be utilized for training programs and establishing dialysis units, and thus meet the growing demands for renal replacement therapy. PD should be encouraged and adopted as first modality of renal replacement therapy considering its ease and economy.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26656132     DOI: 10.1159/000441574

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  5 in total

Review 1.  Changes in the worldwide epidemiology of peritoneal dialysis.

Authors:  Philip Kam-Tao Li; Kai Ming Chow; Moniek W M Van de Luijtgaarden; David W Johnson; Kitty J Jager; Rajnish Mehrotra; Sarala Naicker; Roberto Pecoits-Filho; Xue Qing Yu; Norbert Lameire
Journal:  Nat Rev Nephrol       Date:  2016-12-28       Impact factor: 28.314

Review 2.  Home hemodialysis: a comprehensive review of patient-centered and economic considerations.

Authors:  Rachael C Walker; Kirsten Howard; Rachael L Morton
Journal:  Clinicoecon Outcomes Res       Date:  2017-02-16

3.  Focus on better care and ethics: Are medical ethics lagging behind the development of new medical technologies?

Authors:  Sharon Einav; Otavio T Ranzani
Journal:  Intensive Care Med       Date:  2020-05-27       Impact factor: 17.440

4.  Machine Learning Prediction Models for Chronic Kidney Disease Using National Health Insurance Claim Data in Taiwan.

Authors:  Surya Krishnamurthy; Kapeleshh Ks; Erik Dovgan; Mitja Luštrek; Barbara Gradišek Piletič; Kathiravan Srinivasan; Yu-Chuan Jack Li; Anton Gradišek; Shabbir Syed-Abdul
Journal:  Healthcare (Basel)       Date:  2021-05-07

5.  Reduced White Matter Integrity in Patients With End-Stage and Non-end-Stage Chronic Kidney Disease: A Tract-Based Spatial Statistics Study.

Authors:  Yuhan Jiang; Qiuyi Gao; Yangyingqiu Liu; Bingbing Gao; Yiwei Che; Liangjie Lin; Jian Jiang; Peipei Chang; Qingwei Song; Weiwei Wang; Nan Wang; Yanwei Miao
Journal:  Front Hum Neurosci       Date:  2021-12-10       Impact factor: 3.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.